AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Cefixime; Clavulanic Acid (Clavulanate Potassium)
11 registrations across 1 African market— 11 active
Markets with Cefixime; Clavulanic Acid (Clavulanate Potassium)
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Atrimax 325 mg Tablets_ Tablet | 🇳🇬Nigeria | Evans Therapeutics Limited | active | Nov 2030 |
| Podaxef 162.5 Dispersible Tablets Dispersible tablet | 🇳🇬Nigeria | Marcson Healthcare Limited | active | Dec 2028 |
| Cefexiclav 325 Tablets Tablet | 🇳🇬Nigeria | SJS Life Sciences Limited | active | Jul 2028 |
| Cefexiclav Powder for Oral Suspension 50 mg/31.25 mg/5 mL Suspension | 🇳🇬Nigeria | SJS Life Sciences Limited | active | Jul 2028 |
| Afrixime CLV 325 Tablets Tablet | 🇳🇬Nigeria | Chanrai HealthCare Limited | active | Dec 2026 |
| Bactacef 325 Tablets** Tablet | 🇳🇬Nigeria | Synermed Nig Ltd | active | Oct 2026 |
| Chemityll 325 Tablets** Tablet | 🇳🇬Nigeria | Chez Resources Pharmaceutical Limited | active | Jun 2026 |
| Cfxclav 325 Tablet (check pack size) Tablet | 🇳🇬Nigeria | Aquatix Pharmaceuticals Limited | active | May 2026 |
| Gramocef-CV Tablets** Tablet | 🇳🇬Nigeria | Micro Nova Pharmaceuticals Ind Ltd | active | Feb 2026 |
| Marcfix Powder for Oral Suspension** Powder for suspension | 🇳🇬Nigeria | Marcson Healthcare Limited | active | Feb 2026 |
| Marcfix 325 Tablets** Tablet | 🇳🇬Nigeria | Marcson Healthcare Limited | active | Feb 2026 |
Cefixime; Clavulanic Acid (Clavulanate Potassium) in Africa — Regulatory Overview
Cefixime; Clavulanic Acid (Clavulanate Potassium) is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Nigeria. AfricaRegulatory refreshes this data daily from official government sources.
Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.